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A B S T R A C T
Epidemiology and health economics have systemic interdependencies. The identification of the economic out-
comes of any disease is operated by overlapping its epidemiology with the economic functions of the impacted
entities. This communication presents two epidemiologic-economic models designed to evaluate the economic
burden of cystic echinococcosis and leishmaniasis in Veneto (Northeastern Italy). Following a One Health ap-
proach, the research integrates expertise from different disciplines and institutions and fulfilled its first stage by
defining the relevant cost categories and the data collection strategy for the two diseases in the study area. The
two models identify the relevant epidemiological factors and the economic outcomes of infections in both an-
imals and humans. The results, visualized in flow charts indicating the types of costs associated with these
zoonoses, will guide data collection and the epidemiologic and economic assessment in the next research stages.
This experience shows that One Health methods, although still innovative or unusual in many scientific and
professional contexts, can be applied by using relatively limited resources and already available professional
skills.
1. Introduction: seeking a One Health approach for
echinococcosis and leishmaniasis in a hypo-endemic area
This communication concerns the methodology applied to imple-
ment a research project on cystic echinococcosis (CE) and leishmaniasis
in Veneto, a region of 4.9 million inhabitants in Northeastern Italy. CE
is originated by infections with the larval stage of the tapeworm
Echinococcus granulosus sensu lato. Canids (definitive hosts) harbour
adult parasites, while larvae develop in several livestock species (in-
termediate hosts) and also in humans (accidental intermediate hosts)
[1–4]. The only agent of human leishmaniasis (HumL) in Italy is
Leishmania infantum, a protozoan transmitted by Phlebotomus sandflies
that can determine important illness, especially in non-fully immune-
competent individuals. In the study area, as in all Southern Europe,
dogs represent the main reservoir of this pathogen, which also causes
canine leishmaniasis (CanL) [5–8]. Both CE and leishmaniasis have
high public health impacts worldwide [3,5], recognise domestic ani-
mals as reservoirs, and are considered emerging and hypo-endemic in
Veneto, with verified circulation in animal populations [4,8,9] and
human cases recorded [10,11].
The main objectives of the research – funded through the person-
time costs of the experts from the different institutions involved and a
small university grant – are (i) the evaluation of the costs currently bore
by the population and the health services of the region for the two
diseases, and (ii) the assessment of possible interventions. The research
encompasses three stages: the first includes an analysis of the epide-
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miological characteristics of the two diseases in the region, the identi-
fication of their costs, and the design of a data collection strategy; the
second consists in data collection and epidemiologic and economic
assessments; and the last covers result analysis and evaluation of pos-
sible measures to inform public health decision-makers. The research
approach is inspired by One Health concepts and practices [12,13], in
particular, systems thinking and inter/trans-disciplinarity, which
shaped both the selection of the heterogeneous expertise involved in the
study and the work organization. Until now, the first stage of the pro-
ject has been completed, by identifying, respectively for CE and leish-
maniasis, the interrelations of the relevant disease impacts on animal
and human health, the environment, and the socioeconomic domain.
Here we present the methodological aspects of the project and two
epidemiologic-economic models (EEMs) that describe, for each disease,
the interdependencies of the outcomes and their economic con-
sequences, up to the definition of data collection strategies for cost
evaluation.
2. Integrated expertise and systemic interdependencies between
epidemiology and health economics: the construction of
epidemiologic-economic models
Inter/trans-disciplinarity and systems thinking are functionally in-
terrelated and increasingly applied to health issues [14–17] especially
in the One Health context [12,15,18–23]. In this study, they allowed to
size the epidemiologic and socioeconomic complexity of CE and leish-
maniasis through the integration of interdisciplinary expertise and the
elaboration of two EEMs.
Seven specialists in human and veterinary parasitology, and eco-
nomics, from different academic and health research institutions and
hospitals form the research team (RT) covering the basic set of
disciplines needed. The RT interacts with an interdisciplinary network
(IDN) of professionals and scientists operating as an external advisory
board that validates the main steps of the project. The IDN members
have been selected through an analysis of the integrative expertise
needed to widen the RT institutional and operational perspective in
critical aspects of public health services' management, daily veterinary
professional practice, CE and leishmaniasis control programs, and One
Health research and intervention planning (Table 1).
The EEMs explain the transmission mechanisms of CE and leish-
maniasis in the region and their costs. Conceptually, the models are
based on the interrelations between epidemiology and health eco-
nomics [24–26]: the spread of pathogens in animals and humans and
the distribution and intensity of symptoms cause efficiency losses that
can be evaluated in economic terms by overlapping the disease epide-
miology with the economic functions of the impacted entities [27–30].
This exercise supports decision making for cost-effective health inter-
ventions.
The EEMs have been built as systems within the boundaries set by
the study objectives, by identifying the relevant functional elements
and the feedbacks determining the CE and Leishmaniasis outcomes and
the related costs. This process resulted from the RT and IDN interaction.
The first tentative models were submitted by the RT to the IDN mem-
bers. Based on the comments received, revised versions were elabo-
rated, resubmitted and then discussed between the RT and the IDN in a
one-day meeting, where the final EEMs were approved.
Two flowcharts (Figs. 1 and 2) show the cause-effect links within
the EEMs. This visual approach, well-grounded in epidemiology [31]
and many applications of the systems theory [32,33], boosted the
transdisciplinary system-building process. The EEMs allow a qualitative
identification of CE and leishmaniasis costs in the region and the type of
data needed to develop the following stages of the project that will be
Table 1
Project's research team members (RT) and supervisors of the external interdisciplinary network (IDN): affiliations, background, expertise, and contributions.
Member Affiliation Disciplinary background Specific expertise Contribution to the project
RT1 Academic institute (Italy) Vet. medicine, parasitology Epidemiology of CE and CanL Project planning, project coordination
RT2 Academic institute (Italy) Agricultural economics Agricultural and animal health
economics
Project planning, economic evaluation
RT3 Academic institute (Italy) Agricultural economics Agricultural and animal health
economics
Project planning, economic evaluation
RT4 Academic institute (Italy) Vet. medicine, epidemiology Epidemiology and modelling Conceptualization of epidemiologic aspects
RT5 Vet. public health and research
institute (Italy)
Vet. medicine, parasitology Epidemiology and Diagnostics related to
CE and CanL
Conceptualization of veterinary aspects
RT6 Hospital research institute (Italy) Hum. medicine, tropical diseases Epidemiology and clinical aspects of
Human CE
Conceptualization of human CE aspects
RT7 Hospital research institute (Italy) Hum. medicine, tropical diseases Epidemiology and clinical aspects of
HumL
Conceptualization of HumL aspects
IDN1 Regional health authority (Veneto) Hum. medicine, management Preventive human health Decision-makers perspective for human public
health
IDN2 Regional health authority (Veneto) Vet. medicine, management Veterinary public health Decision-makers perspective for veterinary
health
IDN3 Local health authority (Verona
District)
Vet. medicine Veterinary public health, animal health Perspective of local veterinary services
IDN4 Private professional (Italy) Vet. medicine Professional veterinarian (pet sector) Perspective of dog owners' and vet. private
practice
IDN5 National Institute of Health (Italy) Epidemiology, public health CE (international expert) Perspective from a wide experience of CE control
IDN6 National Institute of Health (Italy) Epidemiology, public health Leishmaniasis (international expert) Perspective from a wide experience of
leishmaniasis control
IDN7 Academic institute (UK) Vet. medicine, vet. economics, One
Health
One Health (international expert) One Health perspective and overall revision
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validated by the IDN through similar iterative procedures.
3. Cystic echinococcosis: epidemiologic-economic model and data
collection strategy
In the CE flowchart (Fig. 1) the distinction between the epidemio-
logical factors originating inside and outside the study area, re-
presented by a map of the region, is indicated by a dashed line. The
origin of the first CE animal infections in the region is unknown. Pre-
sently, around one hundred autochthonous cases of bovine CE are de-
tected by local slaughterhouses every year [4]. Despite CE is supposed
to affect mainly sheep in Veneto, no data on this species are available
from slaughterhouses. Dogs positive for E. granulosus have been found
in the last years through active surveillance [9]. Bovine CE is evenly
distributed throughout the region [4], supporting the hypothesis of a
moderately widespread environmental contamination of E. granulosus
eggs (represented by red dots in the figure) that are a source of human
infections. The cited studies prove the presence of an autochthonous
cycle of the parasite (represented in Fig. 1 with the grey arrows con-
necting the boxes of positive dogs and positive sheep), hence possible
local transmission to humans. Few human CE cases are treated in Ve-
neto hospitals every year and the origin of such infections is largely
unknown. The majority of patients come from other countries or Italian
regions endemic for CE [10,34–35].
Data collection aims at estimating the annual economic burden of
CE in the region. Considering the emerging nature of the disease, hence
its low prevalence in the region, the RT and the IDN agreed that data
search will cover over ten years to detect temporal and spatial trends of
the infection. Given the impossibility to distinguish with certainty the
autochthonous from the non-autochthonous human cases, the IDN ac-
cepted the RT assumption that a CE patient resident in Veneto and born
in the region or another non-endemic area will be considered an “au-
tochthonous case”. For slaughtered cattle and sheep, animal move-
ments can be tracked in the veterinary information system to operate
this distinction.
For the evaluation of human CE costs, patients will be classified
according to the three main disease management protocols: surgical,
medical, and “watch and wait”. The relevant animal CE costs are re-
lated to weight losses, decreased milk production and offal con-
demnation in cattle and sheep, and to the treatment of dogs at risk.
Table 2 shows a synthesis of the CE data collection strategy based on
the relevant cost categories as settled between the RT and the IDN.
Other possible costs related to the current level of the infection in the
region have been considered negligible.
Fig. 1. Epidemiologic-economic model flowchart of cystic echinococcosis in Veneto.
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4. Leishmaniasis: epidemiologic-economic model and data
collection strategy
The leishmaniasis EEM also distinguishes the epidemiological fac-
tors originating within and outside the study area (Fig. 2).
The parasite was introduced from outside the region, but an auto-
chthonous circulation of L. infantum (represented by the grey arrows
connecting the boxes of positive dogs and sandfly high density in Fig. 2)
has been demonstrated for many local canine populations [8,36].
Ecological conditions suitable for the development of the vector
population can be found in the hilly parts of Veneto [37], where CanL
endemicity is then favoured. In these zones, the territory of the muni-
cipalities with demonstrated parasite circulation in dogs (roughly re-
presented by red diagonal stripes in Fig. 2) has been delimited as the
area “at risk”. The rest of the region seems unapt for the development of
critical sandfly densities. However, a progressive future expansion of
the area at risk is possible because of global warming.
Few human cases of cutaneous and visceral HumL are reported each
year from Veneto hospitals, but their origin is mostly uncertain [11].
The RT and IDN then agreed that one patient residing in a municipality
within the area at risk and born in Veneto or another non-endemic
region will be considered an “autochthonous” HumL case. A distinction
between cutaneous and visceral forms will be applied for the HumL cost
evaluation. Costs for CanL concern the treatment of symptomatic dogs
and the prevention of CanL in the areas at risk. The RT and IDN deci-
sions about leishmaniasis data collection strategy and main cost cate-
gories to be considered are summarised in Table 2.
Table 2
Data collection strategy for the cost evaluation of cystic echinococcosis and leishmaniasis in the analysed region.
Type of cost Data needed for the economic evaluation (analysed period 2001–2017) Data
sources
Cystic echinococcosis (CE) Leishmaniasis
Costs for human health care; Number of human CE cases in residents in the analysed region
by age, sex, and nationality; distribution of liver CE, lung CE,
and other potential localizations;
Number of human cases in residents in the analysed region by
age, sex, and nationality; distribution of cutaneous and
visceral leishmaniosis;
(a)
Diagnostic-therapeutic protocols applied and distribution of
patients' management according to “watch and wait”, medical,
and surgical treatment and respective outcomes;
Diagnostic-therapeutic protocols applied and distribution of
patients' management according to the cutaneous and
visceral forms and respective outcomes;
(a) (b) (c)
Total cost per patient for clinical management, including
diagnostics, hospitalization, surgery and postoperative follow
up, medical treatments and patient monitoring;
Total cost per patient for clinical management, including
diagnostics, hospitalization, post-hospitalization follow-up,
medical treatments and patient monitoring;
(a) (b) (c)
Productivity losses in the human
population;
Patients' disability over time according to the therapeutic
outcomes; gross domestic income per capita in the analysed
region;
Patients' disability over time according to the therapeutic




Livestock production losses Data on cattle and sheep heads, production, and production
systems in the analysed region;
(c) (d) (e)
Number of positive cases recorded in slaughterhouses for cattle
and sheep (and respective livestock categories) from farms of the
analysed region;
(f)
Weight losses and milk production decrease in affected animals;
livestock and livestock product prices;
(c) (g)
Offal condemnations of positive animals at slaughterhouses;
offal market prices; costs for offal disposal;
(c) (f) (g)
Costs for treatments of
symptomatic dogs
Treatment protocols for symptomatic dogs; number of
symptomatic dogs in the region; number of dogs treated in
the region under the different protocols;
(c) (h) (i)
(j)
Unit cost of dog treatment for the different treatment
protocols;
(h) (i) (k)
Costs for preventive treatment of
exposed dogs
Definition of “at-risk” dog and standard preventive treatment
protocol for at-risk dogs; number of at-risk dogs in the region;
number of dogs subjected to preventive treatments;
Definition of a standard preventive treatment protocol; total
number of dogs in the areas where the vector is present;
number of dogs subjected to preventive treatments;
(c) (h) (i)
(j)
Annual unit cost for dog treatment; Annual unit cost for dog preventive treatment; (h) (i) (k)
Costs for surveillance of
susceptible livestock
species;
Notifications from slaughterhouses of infected animals coming
from the analysed region: number and unit costs;
(i) (l)
Investigations on farm outbreaks in the region by the public
veterinary services: number and unit costs;
(i) (l)
Costs related to registrations, periodical reporting and
maintenance of the information system;
(i) (l)
(a) Data from the hospital discharge records (HDRs)
(b) Administrative and financial records of a reference hospital in the analysed region;
(c) Information and data from the scientific literature;
(d) Statistics on population, economy, and agriculture in the analysed region;
(e) Data from the national veterinary information system;
(f) Survey on Italian slaughterhouses receiving animals from the analysed region;
(g) Agricultural price bulletins;
(h) Interviews with private practice veterinarians managing animal health in
farms and veterinary clinics for pets;
(i) Interviews with veterinarians of the public health services
(j) Data from the national canine registry;
(k) Price lists of veterinary medicines;
(l) Administrative and financial records from the veterinary public health
services.
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5. Final considerations
The holistic approach of One Health supports the idea that eco-
nomic evaluations of health interventions should consider the com-
plexity of the human, animal and environmental context to a broad
extent, hence the need for a methodological shift toward inter/trans-
disciplinarity and systems thinking [38]. Fulfilling its first stage, this
research shows the feasibility of such a shift, even with small-scale
projects and limited financial resources. The elaboration of the two
EEMs tested the possibility of setting innovative procedures between
researchers and institutions from different fields. Three aspects of this
exercise should be underlined:
1. the integration of expertise resulting in an effective interdisciplinary
work to identify the main cost categories and plan data collection
for a comprehensive economic evaluation;
2. the cooperation within and between the RT and the IDN leading to
the validation of the EEMs in a wider perspective than that
achievable by a mono-disciplinary institution or group;
3. the optimization of available resources, i.e. individual skills, pro-
fessional roles and institutions already working on different aspects
of the same problems, but usually not coordinated toward specific
goals, especially when dealing with neglected zoonoses like CE and
leishmaniasis.
The definitions of “autochthonous” human cases for the two dis-
eases, based on information from veterinary surveillance (e.g. the de-
limitation of areas at-risk for HumL based on CanL endemicity) are
examples of fruitful interdisciplinary expertise integration and institu-
tional cooperation driven by a One Health approach. The first results of
this project indicate that One Health methods, although still pioneering
or unusual in many scientific and professional contexts, can be im-
plemented with limited resources and already available capacities.
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